BCG vaccine trial update, with Professor Andreas Diacon

Loading player...
Stellenbosch University Professor Andreas Diacon is the force behind a 500-person clinical trial aimed at determining whether the BCG vaccines many South Africans got as children to protect against TB are indeed a shield against Covid-19. The trial involves revaccination of BCG that’s been universally applied in South Africa since 1973. Numerous reports have pointed out a correlation between infection rates for countries where BCG is universally administered as being far lower than in those countries like the USA, Italy and Belgium where it was never used. Learn more about your ad choices. Visit megaphone.fm/adchoices
13 Jul 2020 6AM English South Africa Investing · Business News

Other recent episodes

Eskom's nuclear nightmare returns: Zuma-era ghost returns to haunt St Francis

Is South Africa about to repeat its most expensive infrastructure mistakes? Ten years after a corruption-laden Russia/Zuma initiative was shelved, the controversial proposal for a nuclear power plant at Thyspunt near St Francis is back on the table. Communities in the Eastern Cape are sounding the alarm at a siting…
28 Apr 10AM 33 min

Jock of the Bushveld returns: AI brings a South African classic back to life

Jock of the Bushveld, the classic story of how the runt of the litter became the trusted, gutsy companion of Sir Percy FitzPatrick during South Africa’s goldmining era, is one of the country’s most enduring stories. The book once outsold the Bible locally and was adapted into a feature film…
24 Apr 5AM 21 min

Alec Hogg assesses BNC#8: Clem Sunter's penny has finally dropped

Download and read the BNC#8 post-conference PDF here: https://bit.ly/4eB6uCi In a candid address to the Hermanus Rotary Club, BizNews editor Alec Hogg reflects on the key takeaways from BizNews Conference 8, unpacking South Africa’s economic stagnation, governance failures, and the growing realisation that “Pretoria will not provide.” Drawing on insights…
24 Apr 8AM 25 min